SEC Form 4 research
| Issuer | Imprimis Pharmaceuticals, Inc. |
|---|---|
| Tickers | TDLP.OB, IMMY, HROW, TDLP |
| Reporting owners | 39 |
| Officers and directors | 6 |
| Last public filing | 2026-08-18 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-17 | 2026-08-14 | Shojaei Amir | S | 11,250 | $40 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.